Abstract
Mouse antiserum against isologous heat-aggregated immunoglobulins (MAAS), on repeated injection into animals, prolonged the survival of skin allografts, facilitated the development of Moloney sarcoma, reduced the latent period of appearance of tumors, sharply increased the yield of tumors which in most cases led to death of the mice, disturbed the normal age barrier for induction of fibrosarcomas, and sharply reduced the intensity of development of Rauscher leukemia. This effect of MAAS on transplantation and antitumor immunity is immunological in nature.
Similar content being viewed by others
Literature Cited
E. V. Gruntenko, Immunity and the Development of Malignant Tumors [in Russian], Novosibirsk (1977).
A. Ya. Kul'berg, V. V. Khorobrykh, I. A. Tarkhanova, et al., Byull. Éksp. Biol. Med., No. 6, 73 (1974).
V. V. Khorobrykh, D. R. Kaulen, and T. A. Golovanova, Ontogenez, No. 2, 131 (1978).
L. N. Chernousova, A. Ya. Kul'berg, S. A. Simonyan, et al., Byull. Éksp. Biol. Med., No. 12, 698 (1977).
A. C. Allison and L. W. Law, Proc. Soc. Exp. Biol. (New York),127, 207 (1968).
A. C. Allison and R. B. Taylor, Cancer Res.,27, 703 (1967).
A. C. Allison, J. H. Monga, and V. Hammond, Nature,255, 746 (1974).
R. E. Billingham and P. B. Medawar, J. Exp. Biol.,28, 385 (1951).
Rights and permissions
About this article
Cite this article
Kaulen, D.R., Snegireva, A.E., Khorobrykh, V.V. et al. Action of mouse antiserum against isologous aggregated immunoglobulins on transplantation and antitumor immunity. Bull Exp Biol Med 87, 454–456 (1979). https://doi.org/10.1007/BF00806681
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00806681